IRIS Accounts Production v24.3.0.553 12052443 Board of Directors 1.5.23 30.4.24 30.4.24 healthcare services. false true true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh120524432023-04-30120524432024-04-30120524432023-05-012024-04-30120524432022-04-30120524432022-05-012023-04-30120524432023-04-3012052443ns15:EnglandWales2023-05-012024-04-3012052443ns14:PoundSterling2023-05-012024-04-3012052443ns10:Director12023-05-012024-04-3012052443ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3012052443ns10:SmallEntities2023-05-012024-04-3012052443ns10:Audited2023-05-012024-04-3012052443ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3012052443ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3012052443ns10:FullAccounts2023-05-012024-04-3012052443ns10:Director32023-05-012024-04-3012052443ns10:RegisteredOffice2023-05-012024-04-3012052443ns10:Director22023-05-012024-04-3012052443ns5:CurrentFinancialInstruments2024-04-3012052443ns5:CurrentFinancialInstruments2023-04-3012052443ns5:Non-currentFinancialInstruments2024-04-3012052443ns5:Non-currentFinancialInstruments2023-04-3012052443ns5:ShareCapital2024-04-3012052443ns5:ShareCapital2023-04-3012052443ns5:RetainedEarningsAccumulatedLosses2024-04-3012052443ns5:RetainedEarningsAccumulatedLosses2023-04-3012052443ns5:ShareCapital2022-04-3012052443ns5:RetainedEarningsAccumulatedLosses2022-04-3012052443ns5:RetainedEarningsAccumulatedLosses2022-05-012023-04-3012052443ns5:RetainedEarningsAccumulatedLosses2023-05-012024-04-301205244312023-05-012024-04-3012052443ns5:OwnedAssets2023-05-012024-04-3012052443ns5:OwnedAssets2022-05-012023-04-3012052443ns5:PlantMachinery2023-04-3012052443ns5:PlantMachinery2023-05-012024-04-3012052443ns5:PlantMachinery2024-04-3012052443ns5:PlantMachinery2023-04-3012052443ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-04-3012052443ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-04-3012052443ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-04-3012052443ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2023-04-3012052443ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-04-3012052443ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-04-3012052443ns5:RetainedEarningsAccumulatedLosses2023-04-301205244312023-05-012024-04-30
REGISTERED NUMBER: 12052443 (England and Wales)















Report of the Directors and

Financial Statements for the Year Ended 30 April 2024

for

Healthcare Anywhere Ltd

Healthcare Anywhere Ltd (Registered number: 12052443)






Contents of the Financial Statements
for the Year Ended 30 April 2024




Page

Company Information 1

Report of the Directors 2

Report of the Independent Auditors 4

Income Statement 8

Balance Sheet 9

Statement of Changes in Equity 10

Notes to the Financial Statements 11


Healthcare Anywhere Ltd

Company Information
for the Year Ended 30 April 2024







DIRECTORS: K Hinton
Mrs J M Sherry





REGISTERED OFFICE: York House Main Street
Ullesthorpe
Lutterworth
LE17 5BT





REGISTERED NUMBER: 12052443 (England and Wales)





AUDITORS: Forvis Mazars LLP
Chartered Accountants and Statutory Auditor
First Floor
2 Chamberlain Square
Birmingham
B3 3AX

Healthcare Anywhere Ltd (Registered number: 12052443)

Report of the Directors
for the Year Ended 30 April 2024

The directors present their report with the financial statements of the Company for the year ended 30 April 2024.

EVENTS SINCE THE END OF THE YEAR
On 8 May 2024, Healthnet Homecare (UK) Limited purchased the entire issued share capital of the Company.

On 29 October 2024, the entire share capital of the Socius Pharma Group was purchased by Apollo 2024 Bidco Limited, the ultimate parent company of which is Apollo 2024 Topco Limited.

Additional information can be found in the post balance events sheet note and the ultimate controlling party note.

DIRECTORS
K Hinton has held office during the whole of the period from 1 May 2023 to the date of this report.

Other changes in directors holding office are as follows:

Mrs J M Sherry was appointed as a director after 30 April 2024 but prior to the date of this report.

J M M Taylor ceased to be a director after 30 April 2024 but prior to the date of this report.

GOING CONCERN
The financial statements have been prepared on a going concern basis. The company had net liabilities at the year end, however, post the balance sheet date it has become a member of the Socius Pharma group. The company's new parent undertaking, Healthnet Homecare (UK) Limited, has agreed to provide support for the company for at least twelve months following the date of the financial statements. In addition, the directors have prepared a going concern assessment based on forecasts for a period up to April 2026, including realistic downside scenarios. On this basis, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. The directors therefore continue to adopt the going concern basis in preparing the financial statements.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- state whether applicable accounting standards have been followed, subject to any material departures disclosed and as explained in the financial statements;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS
On 1 June 2024 Mazars LLP changed its name to Forvis Mazars LLP. The auditors, Forvis Mazars LLP, will be proposed for re-appointment at the forthcoming Annual General Meeting.


Healthcare Anywhere Ltd (Registered number: 12052443)

Report of the Directors
for the Year Ended 30 April 2024

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





K Hinton - Director


16 January 2025

Report of the Independent Auditors to the Members of
Healthcare Anywhere Ltd

Opinion
We have audited the financial statements of Healthcare Anywhere Limited (the 'Company') for the year ended 30 April 2024, which comprise the Income Statement, Balance Sheet, Statement of Changes in Equity and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
_
In our opinion the financial statements:

- give a true and fair view of the state of the Company's affairs as at 30 April 2024 and of its loss for the year then ended;

- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

- have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the original financial statements were authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The other information comprises the information included in the Report of the Directors and financial statements, other than the financial statements and our auditor's report thereon. The Directors are responsible for the other information contained within the Report of the Directors. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:

- the information given in the Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

- the Directors' Report has been prepared in accordance with applicable legal requirements.

Report of the Independent Auditors to the Members of
Healthcare Anywhere Ltd


Matters on which we are required to report by exception
In the light of our knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Directors' Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

- adequate accounting records have not been kept, or returns adequate for our audit have not been received from
branches not visited by us; or

- the financial statements are not in agreement with the accounting records and returns; or

- certain disclosures of directors' remuneration specified by law are not made; or

- we have not received all the information and explanations we require for our audit; or

- the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemption in preparing the Directors' Report and from the requirement to prepare a Strategic Report.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities, set out on page 2, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic
alternative but to do so.

Report of the Independent Auditors to the Members of
Healthcare Anywhere Ltd


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from
material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion.
Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud.

Based on our understanding of the company and its industry, we considered that non-compliance with the following laws and regulations might have a material effect on the financial statements: employment regulation, health and safety regulation, anti-money laundering regulation.

To help us identify instances of non-compliance with these laws and regulations, and in identifying and assessing the risks of material misstatement in respect to non-compliance, our procedures included, but were not limited to:

- Inquiring of management and, where appropriate, those charged with governance, as to whether the company is in
compliance with laws and regulations, and discussing their policies and procedures regarding compliance with laws and regulations;

- Inspecting correspondence, if any, with relevant licensing or regulatory authorities;

- Communicating identified laws and regulations to the engagement team and remaining alert to any indications of non-compliance throughout our audit; and

- Considering the risk of acts by the company which were contrary to applicable laws and regulations, including fraud.

We also considered those laws and regulations that have a direct effect on the preparation of the financial statements, such as tax legislation, pensions legislation and the Companies Act 2006.

In addition, we evaluated the directors' and management's incentives and opportunities for fraudulent manipulation of the financial statements, including the risk of management override of controls, and determined that the principal risks related to posting manual journal entries to manipulate financial performance, management bias through judgements and assumptions in significant accounting estimates, revenue recognition (which we pinpointed to the cut-off assertion), and significant one-off or unusual transactions.

Our audit procedures in relation to fraud included but were not limited to:

- Making enquiries of the directors and management on whether they had knowledge of any actual, suspected or
alleged fraud;

- Gaining an understanding of the internal controls established to mitigate risks related to fraud;

- Discussing amongst the engagement team the risks of fraud; and

- Addressing the risks of fraud through management override of controls by performing journal entry testing.

There are inherent limitations in the audit procedures described above and the primary responsibility for the prevention and detection of irregularities including fraud rests with management. As with any audit, there remained a risk of non-detection of irregularities, as these may involve collusion, forgery, intentional omissions, misrepresentations or the override of internal controls.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Report of the Independent Auditors to the Members of
Healthcare Anywhere Ltd


Use of our report
This report is made solely to the Company's members as a body in accordance with Chapter 3 of Part 16 of the
Companies Act 2006. Our audit work has been undertaken so that we might state to the Company's members those
matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members as a body for our audit work, for this report, or for the opinions we have formed.




Elisa Howe (Senior Statutory Auditor)
for and on behalf of Forvis Mazars LLP
Chartered Accountants and Statutory Auditor
First Floor
2 Chamberlain Square
Birmingham
B3 3AX

17 January 2025

Healthcare Anywhere Ltd (Registered number: 12052443)

Income Statement
for the Year Ended 30 April 2024

30.4.24 30.4.23
Notes £    £   

TURNOVER 133,041 199,743

Cost of sales 38,826 55,778
GROSS PROFIT 94,215 143,965

Administrative expenses 206,518 170,121
OPERATING LOSS 4 (112,303 ) (26,156 )


Interest payable and similar expenses 633 871
LOSS BEFORE TAXATION (112,936 ) (27,027 )

Tax on loss - -
LOSS FOR THE FINANCIAL YEAR (112,936 ) (27,027 )

Healthcare Anywhere Ltd (Registered number: 12052443)

Balance Sheet
30 April 2024

30.4.24 30.4.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 - 500

CURRENT ASSETS
Debtors 6 77,915 69,858
Cash at bank 18,425 32,782
96,340 102,640
CREDITORS
Amounts falling due within one year 7 140,349 24,613
NET CURRENT (LIABILITIES)/ASSETS (44,009 ) 78,027
TOTAL ASSETS LESS CURRENT
LIABILITIES

(44,009

)

78,527

CREDITORS
Amounts falling due after more than one year 8 10,400 20,000
NET (LIABILITIES)/ASSETS (54,409 ) 58,527

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 10 (54,411 ) 58,525
(54,409 ) 58,527

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 16 January 2025 and were signed on its behalf by:





K Hinton - Director


Healthcare Anywhere Ltd (Registered number: 12052443)

Statement of Changes in Equity
for the Year Ended 30 April 2024

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 May 2022 2 85,552 85,554

Changes in equity
Deficit for the year - (27,027 ) (27,027 )
Total comprehensive income - (27,027 ) (27,027 )
Balance at 30 April 2023 2 58,525 58,527

Changes in equity
Deficit for the year - (112,936 ) (112,936 )
Total comprehensive income - (112,936 ) (112,936 )
Balance at 30 April 2024 2 (54,411 ) (54,409 )

Healthcare Anywhere Ltd (Registered number: 12052443)

Notes to the Financial Statements
for the Year Ended 30 April 2024

1. STATUTORY INFORMATION

Healthcare Anywhere Ltd is a private company, limited by shares, registered in England and Wales. The Company's registered number and registered office address can be found on the Company information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The Company's functional and presentational currency is the Pound Sterling rounded to the nearest pound.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Going concern
The financial statements have been prepared on a going concern basis. The company had net liabilities at the year end, however, post the balance sheet date it has become a member of the Socius Pharma group. The company's new parent undertaking, Healthnet Homecare (UK) Limited, has agreed to provide support for the company for at least twelve months following the date of the financial statements. In addition, the directors have prepared a going concern assessment based on forecasts for a period up to April 2026, including realistic downside scenarios. On this basis, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. The directors therefore continue to adopt the going concern basis in preparing the financial statements.

Critical accounting judgements and key sources of estimation uncertainty
The preparation of the financial statements in conformity with generally accepted accounting principles requires the directors to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Actual results in the future could differ from those estimates. In this regard, the directors believe that there are no critical accounting policies where judgements or estimations are necessarily applied in the financial statements.

Turnover
Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before turnover is recognised:

Sale of goods

Turnover from the sale of goods is recognised when all of the following conditions are satisfied:
- the Company has transferred the significant risks and rewards of ownership to the buyer;
- the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
- the amount of turnover can be measured reliably;
- it is probable that the Company will receive the consideration due under the transaction; and
- the costs incurred in respect of the transaction can be measured reliably.

Rendering of services

Turnover from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
- the amount of turnover can be measured reliably;
- it is probable that the Company will receive the consideration due under the contract;
- the stage of completion of the contract at the end of the reporting period can be measured reliably; and
- the costs incurred and the costs to complete the contract can be measured reliably.

Healthcare Anywhere Ltd (Registered number: 12052443)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2024

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives as follows:
Plant and machinery etc- 33% on cost

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Fixed assets are reviewed for any indication that the asset may be impaired at each balance sheet date. If such indication exists, the recoverable amount of the asset, is estimated and compared to the carrying amount. Where the carrying amount exceeds its recoverable amount, an impairment loss is recognised in the Income Statement.

Gains and losses on disposal are determined by comparing the proceeds with the carrying amount and are recognised in the Income Statement.

Financial instruments
The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties and loans to related parties.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the parent of a trade debt deferred beyond normal business terms or in case of an out-right short term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Income Statement.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount the Company would receive for the asset if it were to be sold at the reporting date.

Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Healthcare Anywhere Ltd (Registered number: 12052443)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The Company operates a defined contribution pension scheme. Contributions payable to the Company's pension scheme are charged to the Income Statement in the period to which they relate.

Debtors and creditors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Short term creditors are measured at the transaction price. Other financial liabilities including bank loans are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 1 ) .

4. OPERATING LOSS

The operating loss is stated after charging:

30.4.24 30.4.23
£    £   
Depreciation - owned assets 500 499

The results in the Income Statement were derived from continuing activities.

The company has no recognised gains or losses for the year other than the results included in the Income Statement.

Healthcare Anywhere Ltd (Registered number: 12052443)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2024

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 May 2023
and 30 April 2024 1,499
DEPRECIATION
At 1 May 2023 999
Charge for year 500
At 30 April 2024 1,499
NET BOOK VALUE
At 30 April 2024 -
At 30 April 2023 500

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Trade debtors 69,595 69,856
Other debtors 8,320 2
77,915 69,858

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Bank loans and overdrafts (see note 9) 9,600 9,600
Trade creditors 124,749 6,601
Taxation and social security - 5,412
Other creditors 6,000 3,000
140,349 24,613

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
30.4.24 30.4.23
£    £   
Bank loans (see note 9) 10,400 20,000

9. LOANS

An analysis of the maturity of loans is given below:

30.4.24 30.4.23
£    £   
Amounts falling due within one year or on demand:
Bank loans 9,600 9,600

Amounts falling due between one and two years:
Bank loans - 1-2 years 9,600 9,600

Healthcare Anywhere Ltd (Registered number: 12052443)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2024

9. LOANS - continued
30.4.24 30.4.23
£    £   
Amounts falling due between two and five years:
Bank loans - 2-5 years 800 10,400

The loan is unsecured, repayable in installments ending in June 2026 and incurs interest at 2.5%.

10. RESERVES
Retained
earnings
£   

At 1 May 2023 58,525
Deficit for the year (112,936 )
At 30 April 2024 (54,411 )

11. PENSION COMMITMENTS

The Company operates a defined contribution pension scheme. The assets of the scheme are held separately from the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £4,912 (2023: £938). There were no unpaid contributions at the reporting date.

12. RELATED PARTY DISCLOSURES

During the year the company entered into transactions, in the ordinary course of business, with non-wholly owned group entities and related parties.

Transactions entered into and trading balances outstanding as at 30 April 2024 were as follows:

Sales Purchases Amounts due Amounts owed
£    £    £    £   
Healthnet Homecare (UK) Limited 179,441 - 57,931 120,259
Apotheke Consulting - - - -
Partizan - - - -

Transactions entered into and trading balances outstanding as at 30 April 2023 were as follows:



Sales

Purchases

Amounts due
Amounts
owed
£   £   £   £   
Healthnet Homecare (UK) Ltd95,13244,04525,7924,031
Apotheke Consulting-9,000--
Partizan-13,502--

13. POST BALANCE SHEET EVENTS

On 8 May 2024, the entire issued share capital of the Company was purchased by Healthnet Homecare (UK) Limited.

On the 29 October 2024, Apollo 2024 Bidco Limited purchased 100% of the ordinary share capital of Socius Pharma Limited, 490 A ordinary shares and 2,000 B ordinary shares in Global Orphan Limited and 227 B ordinary shares of Healthnet Homecare Limited. Apollo 2024 Bidco Limited is wholly owned by Apollo 2024 Holdco Limited, which is in turn wholly owned by Apollo 2024 Midco Limited, which is in turn wholly owned by Apollo 2024 Topco Limited. As a result of the purchase Apollo 2024 Topco Limited owns the entire issued share capital of the Group. Apollo 2024 Topco Limited is majority owned by CBPE Capital Fund X LP, and accordingly CBPE Capital LLP became the company's ultimate controlling entity at that date.

Healthcare Anywhere Ltd (Registered number: 12052443)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2024

14. ULTIMATE CONTROLLING PARTY

In the opinion of the directors' at the year end the company had no ultimate controlling party.

On 8 May 2024, as disclosed in the post balance sheet events note, Healthnet Homecare (UK) Limited purchased the entire issued share capital of the Company. At that date, Healthnet Homecare (UK) Limited, a company incorporated in England and Wales, became the Company's immediate parent undertaking and Socius Pharma Limited in the opinion of the directors became the company's ultimate parent company and ultimate controlling entity until the 29 October 2024 as explained below.

As a result of the transaction described in the post balance sheet event note, on 29 October 2024, Apollo 2024 Topco Limited became company's ultimate parent company and CBPE Capital LLP became its ultimate controlling entity. Copies of Apollo 2024 Topco Limited’s financial statements can be obtained from Companies House.